Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ranibizumab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03495765
What this trial is testing

To Evaluate the Comparative Efficacy of Lucentis (Ranibizumab) 0.5mg Intravitreal Injection in Patients With Diabetic Macular Oedema (DME) With Well Controlled and Poorly Controlled Diabetes Mellitus

Who this might be right for
Diabetic Macular Oedema
Marsden Eye Specialists 160
Testing effectiveness (Phase 2)Study completedNCT03345082
What this trial is testing

A Dose Ranging Study of OPT-302 With Ranibizumab in Neovascular (Wet) AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Opthea Limited 366
Testing effectiveness (Phase 2)Study completedNCT01914159
What this trial is testing

Ranibizumab In Pigment Epithelium Tears Secondary To Age-Related Macular Degeneration Study

Who this might be right for
Age Related Macular Degeneration
University Hospital, Bonn 24
Testing effectiveness (Phase 2)Study completedNCT01077401
What this trial is testing

Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study

Who this might be right for
Diabetic Macular Edema
Johns Hopkins University 152
Not applicableUnknownNCT01521819
What this trial is testing

Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular Degeneration

Who this might be right for
Retinal Pigment Epithelial Detachment With VascularizationAge Related Macular Degeneration
Oraya Therapeutics, Inc. 12
Testing effectiveness (Phase 2)Study completedNCT00373659
What this trial is testing

An OCT-Guided Variable Dosing Regimen With Ranibizumab for the Treatment of Neovascular AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
University of Miami 40
Not applicableStudy completedNCT00656903
What this trial is testing

High Speed Indocyanine Green Angiography Findings in Ranibizumab Treatment for Wet Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
National Eye Institute (NEI) 75
Large-scale testing (Phase 3)Study completedNCT00545870
What this trial is testing

Bevacizumab Versus Ranibizumab for Diabetic Retinopathy

Who this might be right for
Diabetic RetinopathyDiabetic Macular EdemaProliferative Diabetic Retinopathy
Ursula Schmidt-Erfurth, M.D. 30
Post-approval studies (Phase 4)Study completedNCT01628354
What this trial is testing

Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular Degeneration

Who this might be right for
Choroidal NeovascularizationRetinal Pigment Epithelial Detachment
University of Melbourne 49
Testing effectiveness (Phase 2)Study completedNCT00284089
What this trial is testing

Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Subfoveal Choroidal Neovascularization(CNV) Secondary to Age-related Macular Degeneration (AMD)
Novartis 88
Large-scale testing (Phase 3)Study completedNCT02698566
What this trial is testing

A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS)

Who this might be right for
Macular Edema
Genentech, Inc. 35
Early research (Phase 1)Study completedNCT02543229
What this trial is testing

Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD

Who this might be right for
Eye DiseasesMacular DegenerationRetinal Diseases+2 more
Opthea Limited 51
Testing effectiveness (Phase 2)Study completedNCT02510794
What this trial is testing

Study of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Patients With Subfoveal Neovascular Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
Genentech, Inc. 225
Large-scale testing (Phase 3)Ended earlyNCT01402544
What this trial is testing

Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab

Who this might be right for
Age-Related Macular Degeneration
University of California, San Diego 20
Post-approval studies (Phase 4)WithdrawnNCT03059277
What this trial is testing

Intravitreal Alfibercept for Center Involved DME Previously Managed With Intravitreal Ranibizumab

Who this might be right for
Diabetic Macular Edema
Southeast Clinical Research Associates, LLC
Post-approval studies (Phase 4)UnknownNCT03458923
What this trial is testing

Intravitreal Diclofenac Versus Intravitreal Ranibizumab for the Treatment of Diabetic Macular Edema.

Who this might be right for
Diabetic Macular Edema
Cairo University 30
Large-scale testing (Phase 3)UnknownNCT02328118
What this trial is testing

25-Gauge Vitrectomy With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in China

Who this might be right for
Proliferative Diabetic Retinopathy
JUNYAN ZHANG 120
Post-approval studies (Phase 4)UnknownNCT00813891
What this trial is testing

Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration

Who this might be right for
Macular DegenerationVisual Acuity
McGill University Health Centre/Research Institute of the McGill University Health Centre 180
Large-scale testing (Phase 3)Study completedNCT01840410
What this trial is testing

Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization.

Who this might be right for
Choroidal Neovascularization (CNV)
Novartis Pharmaceuticals 183
Early research (Phase 1)UnknownNCT01011374
What this trial is testing

Impact of Lucentis on Psychological Morbidity in Patients With Retinal Vein Occlusion

Who this might be right for
Venous Retinal Branch OcclusionCentral Retinal Vein OcclusionRetinal Vein Occlusion+1 more
Retina Associates of Cleveland, Inc 45
Next Page